These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 28161579)
21. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response. Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848 [TBL] [Abstract][Full Text] [Related]
22. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine. Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212 [TBL] [Abstract][Full Text] [Related]
23. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Li X; Liu R; Tang H; Jin M; Chen H; Qian P Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351 [TBL] [Abstract][Full Text] [Related]
24. Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site. Cubillos C; de la Torre BG; Bárcena J; Andreu D; Sobrino F; Blanco E Virol J; 2012 Mar; 9():66. PubMed ID: 22416886 [TBL] [Abstract][Full Text] [Related]
25. Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease. Dong YM; Cai JC; Chen HT; Chen L Antiviral Res; 2016 Oct; 134():108-116. PubMed ID: 27565990 [TBL] [Abstract][Full Text] [Related]
26. A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity. Dong H; Lu Y; Zhang Y; Mu S; Wang N; Du P; Zhi X; Wen X; Wang X; Sun S; Zhang Y; Guo H J Virol; 2021 Jul; 95(16):e0017721. PubMed ID: 34011545 [TBL] [Abstract][Full Text] [Related]
27. Indirect ELISA using a multi-epitope recombinant protein to detect antibodies against foot-and-mouth disease virus serotype O in pigs. Cao Y; Zhou W; Xing X; Zhang J; Fu Y; Li K; Sun P; Li P; Bai X; Ma X; Bao H; Li D; Chen Y; Lu Z; Liu Z J Virol Methods; 2018 Dec; 262():26-31. PubMed ID: 30244034 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep. Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422 [TBL] [Abstract][Full Text] [Related]
30. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs. Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640 [TBL] [Abstract][Full Text] [Related]
31. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs. Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796 [TBL] [Abstract][Full Text] [Related]
32. Development of Protective Immunity against Inactivated Iranian Isolate of Foot-and-Mouth Disease Virus Type O/IRN/2007 Using Gamma Ray-Irradiated Vaccine on BALB/c Mice and Guinea Pigs. Motamedi-Sedeh F; Soleimanjahi H; Jalilian AR; Mahravani H; Shafaee K; Sotoodeh M; Taherkarami H; Jairani F Intervirology; 2015; 58(3):190-6. PubMed ID: 26202581 [TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs. Terhuja M; Saravanan P; Tamilselvan RP Biologicals; 2015 Nov; 43(6):437-43. PubMed ID: 26493006 [TBL] [Abstract][Full Text] [Related]
34. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease. You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics. Li P; Bai X; Sun P; Li D; Lu Z; Cao Y; Fu Y; Bao H; Chen Y; Xie B; Liu Z BMC Vet Res; 2012 May; 8():57. PubMed ID: 22591597 [TBL] [Abstract][Full Text] [Related]
36. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease. Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine. Li P; Lu Z; Bai X; Li D; Sun P; Bao H; Fu Y; Cao Y; Chen Y; Xie B; Yin H; Liu Z Vet Res; 2014 May; 45(1):51. PubMed ID: 24885414 [TBL] [Abstract][Full Text] [Related]
38. A bivalent B-cell epitope dendrimer peptide can confer long-lasting immunity in swine against foot-and-mouth disease. Cañas-Arranz R; Forner M; Defaus S; Rodríguez-Pulido M; de León P; Torres E; Bustos MJ; Borrego B; Sáiz M; Blanco E; Andreu D; Sobrino F Transbound Emerg Dis; 2020 Jul; 67(4):1614-1622. PubMed ID: 31994334 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination. Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677 [TBL] [Abstract][Full Text] [Related]